2024 biotech funding tracker: recent highlights …A | neurological disorder therapeutics | preclinical in neuromuscular diseases Holoclara (United States): $16 million series A | worm-derived therapies | preclinical in allergic and autoimmune diseases July 2024: Myricx… February 23, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
In Depth 19 Jun 2024 MASH candidates make a splash after first drug approval …few societies as the most accurate way to describe the disease.” New treatments related to metabolic diseases Indacaterol for the Treatment Obesity and Related Metabolic Diseases – Texas Tech University… June 19, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Feb 2025 Seven companies using metabolomics to decode biology …been instrumental in diagnostic applications, its impact extends into therapeutic development. By elucidating metabolic alterations associated with diseases, metabolomics enables the design of targeted interventions, enhancing the precision and effectiveness… February 13, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Jul 2025 10 biotech companies leading the way in Denmark …to develop, manufacture, and commercialize Novo’s proprietary products in metabolic diseases (including obesity and type 2 diabetes) and a product-by-product exclusive license in cardiovascular diseases. Bavarian Nordic Technology: Vaccines Disease… July 29, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2025 Pushing biotech forward in France: 18 companies to know about …neurodegenerative disorders like Alzheimer’s and Parkinson’s diseases. Cilcare is also conducting the SAPHIR observational study to explore the link between hearing impairments and neurodegenerative diseases. The study aims to develop… June 10, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2022 Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders …development of HU6 and a pipeline of controlled metabolic accelerators to address a range of cardio-metabolic conditions.” About Rivus Pharmaceuticals’ CMAs Nearly half of American adults are living with cardio-metabolic… September 22, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Nov 2024 Seven miRNA-focused companies pioneering new therapies in 2024 …involvement in various diseases – alterations in miRNA expression profiles have been linked to cancer, cardiovascular diseases, and neurodegenerative disorders. This connection positions miRNAs as both potential biomarkers for disease… November 26, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2025 Top biotech deals in June 2025 …a special interest in curing metabolic diseases, most of the medicines up for grabs were small molecules, proteins, and antibodies. Take a look at the top biotech deals that were… July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2024 Top biotech deals of October 2024 …in metabolic diseases continue As always, interest in targeting metabolic diseases remains strong. And once again, Lilly is in the game. It has partnered with insitro, a California-based drug company,… November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Opinion 28 Feb 2023 Life changing treatments for rare disease – a beacon of hope …across the medical spectrum and include cancers, neurological and neuromuscular diseases, metabolic diseases and a multitude of skin, bone, kidney, blood and skeletal disorders. Many have genetic origins, and some… February 28, 2023 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 19 May 2023 Can cardiovascular diseases be cured? The future of heart treatment …over the years increasing our understanding of different types of cardiovascular diseases and their causes. What are the challenges in developing cures for cardiovascular diseases? One of the main challenges… May 19, 2023 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Oct 2024 GPCR therapies: Eight promising biotechs hacking the cell signaling pathway …of diseases like autoimmune disorder Graves’ disease – caused by excess thyroid hormone production – chronic spontaneous urticaria – a skin condition that causes hives – and metabolic diseases. Structure… October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email